124 related articles for article (PubMed ID: 1600396)
1. [Apolipoprotein E mobility between plasma lipoproteins in intravenous administration of fat emulsions (MCT, LCT)].
Steinmetz A; Schwarz S; Richter G
Infusionsther Transfusionsmed; 1992 Feb; 19(1):32-6. PubMed ID: 1600396
[TBL] [Abstract][Full Text] [Related]
2. [Comparative studies of the metabolism of MCT/LCT and LCT emulsions in diabetics].
Wicklmayr M; Rett K; Dietze G; Mehnert H
Infusionsther Klin Ernahr; 1986 Dec; 13(6):287-90. PubMed ID: 3818049
[TBL] [Abstract][Full Text] [Related]
3. In vitro transfer of apolipoproteins from plasma lipoproteins to artificial lipid particles.
Asami H; Iriyama K
Nutrition; 1990; 6(2):143-5. PubMed ID: 2134526
[TBL] [Abstract][Full Text] [Related]
4. [Randomized study comparing long-chain (LCT) and medium-chain (MCT) triglycerides as caloric carriers in postoperative nutritional therapy].
Lünstedt B; Deltz E; Kähler M; Bruhn A
Infusionsther Klin Ernahr; 1987 Apr; 14(2):61-4. PubMed ID: 3112002
[TBL] [Abstract][Full Text] [Related]
5. [A comparative study of fat emulsions clearance test using long chain triglycerides and medium chain triglycerides in volunteers].
He G; Jiang Z; Shu H; Wang X
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1995 Oct; 17(5):379-82. PubMed ID: 8706175
[TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein C-II deficiency syndrome. Clinical features, lipoprotein characterization, lipase activity, and correction of hypertriglyceridemia after apolipoprotein C-II administration in two affected patients.
Baggio G; Manzato E; Gabelli C; Fellin R; Martini S; Enzi GB; Verlato F; Baiocchi MR; Sprecher DL; Kashyap ML
J Clin Invest; 1986 Feb; 77(2):520-7. PubMed ID: 3944267
[TBL] [Abstract][Full Text] [Related]
7. Short-term effects of parenteral nutrition of cholestatic infants with lipid emulsions based on medium-chain and long-chain triacylglycerols.
Socha P; Koletzko B; Demmelmair H; Jankowska I; Stajniak A; Bednarska-Makaruk M; Socha J
Nutrition; 2007 Feb; 23(2):121-6. PubMed ID: 17234505
[TBL] [Abstract][Full Text] [Related]
8. [Clinical studies with fat emulsions containing LCT and MCT].
Eckart J; Neeser G; Adolph M; Hailer S; Wolfram G
Infusionsther Klin Ernahr; 1987 Sep; 14 Suppl 3():38-49. PubMed ID: 3119488
[TBL] [Abstract][Full Text] [Related]
9. [Changes in AI, B and E apolipoproteins induced by infusion of lipid emulsions in critical patients].
Locati L; Zagara G; Feré A
Minerva Anestesiol; 1989 Dec; 55(12):505-8. PubMed ID: 2517678
[TBL] [Abstract][Full Text] [Related]
10. [Intestinal apolipoprotein metabolism].
Steinmetz A
Klin Wochenschr; 1990; 68 Suppl 22():12-8. PubMed ID: 2087069
[TBL] [Abstract][Full Text] [Related]
11. Effect of apolipoprotein E phenotype on plasma lipids and lipoproteins in alcohol abusers.
Liinamaa MJ; Kervinen K; Hannuksela ML; Kesäniemi YA; Savolainen MJ
Alcohol Clin Exp Res; 1997 Jun; 21(4):606-12. PubMed ID: 9194912
[TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein E polymorphism and plasma lipid, lipoprotein, and apolipoprotein levels in Italian children.
Xu CF; Talmud PJ; Angelico F; Del Ben M; Savill J; Humphries SE
Genet Epidemiol; 1991; 8(6):389-98. PubMed ID: 1806408
[TBL] [Abstract][Full Text] [Related]
13. In vivo and in vitro properties of an intravenous lipid emulsion containing only medium chain and fish oil triglycerides.
Ton MN; Chang C; Carpentier YA; Deckelbaum RJ
Clin Nutr; 2005 Aug; 24(4):492-501. PubMed ID: 16054521
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of transfer of apolipoproteins between triacylglycerol-rich particles in lipid emulsions and plasma lipoproteins.
Iriyama K; Carpentier YA
Nutrition; 1994; 10(3):252-4. PubMed ID: 7919678
[TBL] [Abstract][Full Text] [Related]
15. Apolipoprotein C-II modifications associated with an infusion of artificial lipid particles.
Iriyama K; Nishiwaki H; Terashima H; Tonouchi H; Miki C; Suzuki H; Carpentier YA
JPEN J Parenter Enteral Nutr; 1988; 12(1):60-2. PubMed ID: 3125357
[TBL] [Abstract][Full Text] [Related]
16. An apolipoprotein(a) peptide delays chylomicron remnant clearance and increases plasma remnant lipoproteins and atherosclerosis in vivo.
Devlin CM; Lee SJ; Kuriakose G; Spencer C; Becker L; Grosskopf I; Ko C; Huang LS; Koschinsky ML; Cooper AD; Tabas I
Arterioscler Thromb Vasc Biol; 2005 Aug; 25(8):1704-10. PubMed ID: 15905467
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of a mixture of medium-chain triglyceride (75%) and long-chain triglyceride (25%) fat emulsions in the nutritional management of multiple-trauma patients.
Jeevanandam M; Holaday NJ; Voss T; Buier R; Petersen SR
Nutrition; 1995; 11(3):275-84. PubMed ID: 8541696
[TBL] [Abstract][Full Text] [Related]
18. Effects of lipid administration on lymphatic apolipoprotein A-IV and B output and synthesis.
Nishimura M; Seishima M; Ohashi H; Noma A
Am J Physiol; 1996 Aug; 271(2 Pt 1):G322-9. PubMed ID: 8770048
[TBL] [Abstract][Full Text] [Related]
19. Constant infusion rates of lipid emulsions to stabilize plasma triglyceride concentrations: medium-chain triglyceride/long-chain triglyceride emulsions (MCT/LCT) versus LCT.
Iriyama K; Miki C; Inoue T; Kawarabayashi N; Urata H; Shigemori C
Surg Today; 1998; 28(3):289-92. PubMed ID: 9548311
[TBL] [Abstract][Full Text] [Related]
20. Effects of intravenous infusions of commercial fat emulsions (Intralipid 10 or 20%) on rat plasma lipoproteins: phospholipids in excess are the main precursors of lipoprotein-X-like particles.
Hajri T; Férézou J; Lutton C
Biochim Biophys Acta; 1990 Nov; 1047(2):121-30. PubMed ID: 2248969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
